acebutolol has been researched along with Left Ventricular Hypertrophy in 2 studies
Acebutolol: A cardioselective beta-1 adrenergic antagonist with little effect on the bronchial receptors. The drug has stabilizing and quinidine-like effects on cardiac rhythm, as well as weak inherent sympathomimetic action.
acebutolol : An ether that is the 2-acetyl-4-(butanoylamino)phenyl ether of the primary hydroxy group of 3-(propan-2-ylamino)propane-1,2-diol.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sau, F | 1 |
| Seguro, C | 1 |
| Pargentino, E | 1 |
2 other studies available for acebutolol and Left Ventricular Hypertrophy
| Article | Year |
|---|---|
[Chronology of regression of hypertensive ventricular hypertrophy during antihypertensive therapy with beta blockers].
Topics: Acebutolol; Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Echocardi | 1994 |
[Hypertensive heart. Experience in the clinical use of sectral (acebutolol)].
Topics: Acebutolol; Adrenergic beta-Antagonists; Blood Pressure; Humans; Hypertension; Hypertrophy, Left Ven | 1992 |